Lunit, a provider of AI-powered cancer diagnostics and therapeutics, has acquired Volpara Health Technologies, a global leader in breast cancer screening software. Last year when the acquisition was first announced Lunit shared plans to acquire all Volpara shares at AUD 1.15 per share, amounting to a deal worth approximately AUD 292 million (USD 193 million). The acquisition merges Volpara’s advanced breast health…
![](https://femtechinsider.com/wp-content/uploads/2024/05/brandon-suh-lunit-1170x658.jpg)